[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

NGL Fine-Chem Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NGL Fine-Chem Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nichi-Iko Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nichi-Iko Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nicox SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nicox SA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nile Pharmaceuticals & Chemical Industries Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nile Pharmaceuticals & Chemical Industries Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nile Therapeutics, Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nile Therapeutics, Inc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nippon Chemiphar Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nippon Chemiphar Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nippon Shinyaku Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nippon Shinyaku Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

NorDiag ASA. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NorDiag ASA. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nordion Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nordion Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

North China Pharmaceutical Company Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

North China Pharmaceutical Company Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Northeast Pharmaceutical Group Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Northeast Pharmaceutical Group Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Northeast Tiger Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Northeast Tiger Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Northwest Biotherapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Northwest Biotherapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nova BioGenetics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nova BioGenetics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

NovaBay Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NovaBay Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Novadel Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novadel Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

NovaDx Ventures Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NovaDx Ventures Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Novagali Pharma S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novagali Pharma S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Novartis AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novartis AG Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Novartis India Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novartis India Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Novavax, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novavax, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Cellectar Biosciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cellectar Biosciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

November AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

November AG Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Novo Nordisk A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novo Nordisk A/S Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Novogen Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novogen Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

NPS Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NPS Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

NuPathe, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NuPathe, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

NuRx Pharmaceuticals, Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NuRx Pharmaceuticals, Inc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nusep Holdings Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nusep Holdings Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nutra Pharma Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nutra Pharma Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nutraplus India Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nutraplus India Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nuvo Research Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nuvo Research Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nymox Pharmaceutical Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nymox Pharmaceutical Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Oasmia Pharmaceutical AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oasmia Pharmaceutical AB Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Obagi Medical Products, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Obagi Medical Products, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

OBJ Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OBJ Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Ocean Bright Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ocean Bright Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

OctoPlus N.V. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OctoPlus N.V. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sonoma Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sonoma Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Ohr Pharmaceutical, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ohr Pharmaceutical, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

OJSC Pharmstandard Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OJSC Pharmstandard Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Olfactory Biosciences Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Olfactory Biosciences Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Omeros Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Omeros Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Omni Bio Pharmaceutical, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Omni Bio Pharmaceutical, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Omnimmune Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Omnimmune Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

OncoGenex Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OncoGenex Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Oncologix Tech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oncologix Tech, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Oncolytics Biotech Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oncolytics Biotech Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

OncoTherapy Science Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OncoTherapy Science Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Oncothyreon Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oncothyreon Inc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers